IGF1R and prostate neoplasm: In addition, many tumour types, including prostate tumours, upregulate the expression of related insulin receptor (INSR), IGF-1 receptor (IGF-1R), and hybrid INSR/IGF-1Rs [31, 40] further promoting insulin-driven cancer survival pathways [41].